A
Active Biotech AB publ
STO:ACTI
Active Biotech AB publ
STO:ACTI
Price:
0.0433
SEK
1.17%
Market Closed
Market Cap:
kr114.1m
Active Biotech AB publ
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Active Biotech AB publ
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Active Biotech AB publ
STO:ACTI
|
Research & Development
-kr25.2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
18%
|
|
|
Biogaia AB
STO:BIOG B
|
Research & Development
-kr115.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Research & Development
-kr91.4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Research & Development
-kr109m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Research & Development
-kr3.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-20%
|
|
|
BioArctic AB
STO:BIOA B
|
Research & Development
-kr376.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Active Biotech AB publ
Glance View
Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
ACTI Intrinsic Value
HIDDEN
See Also
What is Active Biotech AB publ's Research & Development?
Research & Development
-25.2m
SEK
-25.2m
SEK
Based on the financial report for Dec 31, 2025, Active Biotech AB publ's Research & Development amounts to -25.2m SEK.
What is Active Biotech AB publ's Research & Development growth rate?
Research & Development CAGR 10Y
18%
18%
Over the last year, the Research & Development growth was 6%. The average annual Research & Development growth rates for Active Biotech AB publ have been 16% over the past three years , and 18% over the past ten years .
